Birgit Koch

Birgit Koch is a Full Professor in the Department of Pharmacy at Erasmus MC, affiliated with the Erasmus School of Health Professions. Her work is deeply rooted in clinical pharmacology, with a focus on optimizing drug therapy through pharmacokinetic and pharmacodynamic modeling.

Her research interests span pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, and antibiotic dosing, particularly in vulnerable populations such as critically ill and pediatric patients. She has made significant contributions to the understanding of vancomycin and beta-lactam antibiotic pharmacology.

The recent articles highlight a consistent trend in clinical pharmacology research, emphasizing population pharmacokinetic modeling, individualized dosing, and evidence-based drug monitoring. Her work bridges laboratory data with real-world clinical outcomes, especially in intensive care and oncology settings.

While no specific scientific awards are listed in the provided text, her extensive publication record and leadership in high-impact studies suggest recognition within the field.

She has supervised multiple research outputs, indicating an active role in mentoring junior researchers and contributing to academic training. Although specific grants are not mentioned, her involvement in studies like the DOLPHIN trial implies participation in funded research projects.

Birgit Koch is part of a robust research network at Erasmus MC, collaborating with experts in oncology, infectious diseases, and clinical pharmacy. Her work is integrated into larger clinical research initiatives, particularly those involving drug optimization and patient-centered pharmacotherapy.